US equities
|
NVDA
$238.59
▲+1.99%
SPCX
$167.56
▲+5.41%
MU
$1,062.58
▼-1.15%
TSLA
$380.08
▲+2.56%
MSFT
$525.91
▲+1.62%
SNDK
$1,702.82
▼-1.00%
INTC
$117.03
▼-1.93%
META
$743.18
▲+2.07%
NVDA
$238.59
▲+1.99%
SPCX
$167.56
▲+5.41%
MU
$1,062.58
▼-1.15%
TSLA
$380.08
▲+2.56%
MSFT
$525.91
▲+1.62%
SNDK
$1,702.82
▼-1.00%
INTC
$117.03
▼-1.93%
META
$743.18
▲+2.07%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Globus Medical, Inc. Class A Common Stock
(NY:
GMED
)
77.05
+1.45 (+1.92%)
Delayed Quote
Updated: 2:40 PM EDT, Oct 5, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Globus Medical, Inc. Class A Common Stock
< Previous
1
2
3
4
5
6
7
8
9
...
15
16
Next >
What to Know About This $18 Million Bet on a Rental Business With 35 Years of Dividend Growth
↗
May 31, 2026
McGrath RentCorp delivers modular buildings and equipment rentals to diverse institutional and industrial clients across multiple sectors.
Via
The Motley Fool
Topics
Regulatory Compliance
Globus Medical Inc - A (NYSE:GMED) Shines in Decent Value Screen with Strong Fundamentals
↗
May 29, 2026
Via
Chartmill
2 Growth Stocks Set to Flourishand 1 We Question
May 27, 2026
Growth is a hallmark of all great companies, but the laws of gravity eventually take hold. Those who rode the COVID boom and ensuing tech selloff in 2022 wil...
Via
StockStory
Topics
Bonds
Supply Chain
Globus Medical Inc - A (NYSE:GMED): A Textbook GARP Stock with Strong Growth and Fair Valuation
↗
May 22, 2026
Via
Chartmill
Pembroke Trims Position in Workiva, According to Latest SEC Filing
↗
May 21, 2026
This enterprise software provider delivers cloud-based compliance and reporting solutions to organizations worldwide.
Via
The Motley Fool
Topics
Regulatory Compliance
Globus Medical Inc - A (NYSE:GMED) Passes Navellier's Little Book Screen
↗
May 20, 2026
Via
Chartmill
Globus Medical Inc - A (NYSE:GMED) Screens as a Top-Tier Quality Growth Stock on the Caviar Cruise Investment Model
↗
May 12, 2026
Via
Chartmill
Investment Firm Sells SaaS Stock Worth $14.2 Million, According to Recent SEC Filing
↗
May 21, 2026
Q2 Holdings delivers digital banking platforms to U.S. regional and community financial institutions, enabling secure, cloud-based services.
Via
The Motley Fool
Topics
Regulatory Compliance
Investment Advisor Trims Position in Financial Stock, According to Latest SEC Filing
↗
May 20, 2026
QCR Holdings, Inc. delivers commercial banking and asset management services to Midwest markets through a multi-bank structure.
Via
The Motley Fool
Topics
Regulatory Compliance
Investment Advisor Sells CHEF Shares Worth $8.9 Million, According to Latest SEC Filing
↗
May 20, 2026
Specializing in premium food products, The Chefs' Warehouse serves top restaurants and hospitality clients across North America.
Via
The Motley Fool
Topics
Regulatory Compliance
Supply Chain
Globus Medical (NYSE:GMED) Delivers Massive Q1 Beat, Guides EPS Higher
↗
May 07, 2026
Via
Chartmill
Globus Medical Inc - A (NYSE:GMED) Fits the Affordable Growth Profile
↗
April 30, 2026
Via
Chartmill
Globus Medical Inc - A (NYSE:GMED) Scores High Growth Momentum and Technical Setup Ratings
↗
April 22, 2026
Via
Chartmill
5 Must-Read Analyst Questions From Globus Medical’s Q1 Earnings Call
May 14, 2026
Globus Medical’s first quarter delivered results ahead of Wall Street’s expectations, but the market reacted negatively, with shares declining over 5%. Manag...
Via
StockStory
Topics
Earnings
Economy
Global Alpha Dumps 229,000 Ani Pharmaceuticals (ANIP) Shares Worth $17.9 Million
↗
May 11, 2026
ANI Pharmaceuticals develops and manufactures branded and generic drugs for diverse North American healthcare markets.
Via
The Motley Fool
1 Healthcare Stock with Competitive Advantages and 2 We Brush Off
May 11, 2026
From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. But speed bumps such as inventory de...
Via
StockStory
Globus Medical Inc (NYSE:GMED): A Prime Affordable Growth Stock with Strong Fundamentals
↗
April 01, 2026
Via
Chartmill
Globus Medical Q1 Earnings Call Highlights
↗
May 10, 2026
Globus Medical (NYSE:GMED) reported a strong start to 2026, with first-quarter revenue and earnings rising sharply as the company cited continued momentum in U.S. spine, margin expansion and...
Via
MarketBeat
Topics
Earnings
GMED Q1 Deep Dive: Margin Expansion and Strategy Shift Amid Market Share Gains
May 08, 2026
Medical device company Globus Medical (NYSE:GMED) announced better-than-expected revenue in Q1 CY2026, with sales up 27% year on year to $759.9 million. The ...
Via
StockStory
Topics
Economy
Globus Medical (GMED) Q1 2026 Earnings Transcript
↗
May 07, 2026
Globus Medical (GMED) Q1 2026 Earnings Transcript
Via
The Motley Fool
Globus Medical’s (NYSE:GMED) Q1 CY2026: Beats On Revenue
May 07, 2026
Medical device company Globus Medical (NYSE:GMED) beat Wall Street’s revenue expectations in Q1 CY2026, with sales up 27% year on year to $759.9 million. The...
Via
StockStory
Globus Medical Reports First Quarter 2026 Results
May 07, 2026
From
Globus Medical
Via
GlobeNewswire
Globus Medical (GMED) Reports Q1: Everything You Need To Know Ahead Of Earnings
May 05, 2026
Medical device company Globus Medical (NYSE:GMED) will be reporting earnings this Thursday afternoon. Here’s what you need to know. Globus Medical beat analy...
Via
StockStory
Medical Devices & Supplies - Specialty Q4 Earnings: Globus Medical (NYSE:GMED) is the Best in the Biz
April 26, 2026
The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how medical devices &...
Via
StockStory
2 Cash-Heavy Stocks with Exciting Potential and 1 We Turn Down
April 17, 2026
A surplus of cash can mean financial stability, but it can also indicate a reluctance (or inability) to invest in growth. Some of these companies also face c...
Via
StockStory
Globus Medical Schedules First Quarter Earnings Release and Conference Call
April 16, 2026
From
Globus Medical
Via
GlobeNewswire
2 Reasons to Like GMED and 1 to Stay Skeptical
April 15, 2026
What a fantastic six months it’s been for Globus Medical. Shares of the company have skyrocketed 62.5%, hitting $94.80. This was partly thanks to its solid q...
Via
StockStory
2 Profitable Stocks with Promising Prospects and 1 Facing Challenges
April 08, 2026
Even if a company is profitable, it doesn’t always mean it’s a great investment. Some struggle to maintain growth, face looming threats, or fail to reinvest ...
Via
StockStory
Is Stagflation Creeping Into the Picture?
↗
March 29, 2026
GDP data shows an economy that slowed to a crawl in the fourth quarter of 2025 as inflation picked up.
Via
The Motley Fool
Topics
Economy
Stocks
World Trade
Artivion, Intuitive Surgical, GE HealthCare, LeMaitre, and Globus Medical Shares Plummet, What You Need To Know
March 27, 2026
What Happened? A number of stocks fell in the afternoon session after major indices including the S&P 500 and Dow Jones Industrial Average fell sharply as in...
Via
StockStory
Topics
Government
Stocks
< Previous
1
2
3
4
5
6
7
8
9
...
15
16
Next >
